Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Collegium Pharmaceutical

Biotech & Life Sciences · Cumberland, United States · Founded 2002 · IPO 2015 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.52B
Market cap · Apr/2026
Revenue
$781M
Latest reported FY

Investors

11 investors on Collegium Pharmaceutical's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Boston Millennia Partners
Series B+ 10 investors entered at this stage
Westfield Capital Management
TPG Biotech
TPG
Eventide Asset Management
Frazier Healthcare Partners
RA Capital Management
Skyline Ventures
Longitude Capital
EcoR1 Capital
Rock Springs Capital

Global footprint

Where Collegium Pharmaceutical has talent and traffic

Web traffic by country
14K monthly visits
across markets
🇺🇸 United States86.4%
🇮🇳 India9.3%
🇨🇦 Canada5.7%
Top 3 markets shown

See Collegium Pharmaceutical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo